Family Motivational Intervention in Schizophrenia
- Conditions
- CannabisSchizophrenia
- Interventions
- Behavioral: Family Motivational Intervention
- Registration Number
- NCT01167556
- Brief Summary
Cannabis use by people with schizophrenia is associated with family distress and poor clinical outcomes. Therefore, an Family Motivational Intervention (FMI) was developed to help parents to motivate their child with a diagnoses of recent-onset schizophrenia to reduce cannabis use.
In a single-blind randomised clinical trail with 75 patients with the diagnosis of schizophrenia, parents will be assigned to either FMI or to routine care. Assessments will be conducted at baseline and at a 10- and 22-month follow-up. The study hypothesis is that FMI will be more effective than routine care in reducing (a) cannabis use in patients and (b) distress and sense of burden in parents.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 147
- Clinical diagnosis of schizophrenia or psychotic-related disorder
- Onset of schizophrenia or related disorder within pervious the 10 years
- Cannabis use at least 2 days per week in the 3 months prior to the assessment
- Antipsychotic medication in prescribed or indicated
- At least 10 hours of contact with the parents each week in the last month
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Family Motivational Intervention Family Motivational Intervention An intervention provided to parents consisting of 6 sessions of training in Interactions Skills and 6 sessions training in Motivational Interviewing. Routine care for parents Family Motivational Intervention Routine care for parents consisting of 2 sessions psycho-education and individual support
- Primary Outcome Measures
Name Time Method Cannabis use in patients with a diagnosis of recent-onset schizophrenia 22-month follow-up (15 months after the intervention has ended)
- Secondary Outcome Measures
Name Time Method Medication adherence in patients with a diagnosis of recent-onset schizophrenia 22-month follow-up (15 months after the intervention has ended) Quality of life in patients with recent-onset schizophrenia 22-month follow-up (15 months after the intervention has ended) Stress in parents due to caring for a child with recent-onset schizophrenia 22-month follow-up (15 months after the intervention has ended) Expressed emotion in parents of patients with recent-onset schizophrenia 22-month follow-up (15 months after the intervention has ended)
Trial Locations
- Locations (1)
Academic Medical Center
🇳🇱Amsterdam, North Holland, Netherlands